These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2435061)

  • 81. Pneumopathogenicity of a Sendai virus protease-activation mutant, TCs, which is sensitive to trypsin and chymotrypsin.
    Itoh M; Ming TD; Hayashi T; Mochizuki Y; Homma M
    J Virol; 1990 Nov; 64(11):5660-4. PubMed ID: 2170692
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A protease activation mutant, MVCES1, as a safe and potent live vaccine derived from currently prevailing Sendai virus.
    Wang XL; Itoh M; Hotta H; Homma M
    J Virol; 1994 May; 68(5):3369-73. PubMed ID: 8151795
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Complement-dependent antiviral monospecific antibody-mediated lysis of murine cells coated with Sendai virus or its envelope component.
    Hosaka Y; Fukami Y; Yasuda Y; Bonilla JA
    Infect Immun; 1980 Feb; 27(2):355-63. PubMed ID: 6247274
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Altered budding site of a pantropic mutant of Sendai virus, F1-R, in polarized epithelial cells.
    Tashiro M; Yamakawa M; Tobita K; Seto JT; Klenk HD; Rott R
    J Virol; 1990 Oct; 64(10):4672-7. PubMed ID: 2168957
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Growth properties and F protein cleavage site sequences of naturally occurring human parainfluenza type 2 viruses.
    Bando H; Kawano M; Kondo K; Tsurudome M; Komada H; Nishio M; Ito Y
    Virology; 1991 Sep; 184(1):87-92. PubMed ID: 1651606
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Sendai virus M protein is found in two distinct isoforms defined by monoclonal antibodies.
    de Melo M; Mottet G; Orvell C; Roux L
    Virus Res; 1992 Jun; 24(1):47-64. PubMed ID: 1378238
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Antigenic variation among Sendai virus strains detected by monoclonal antibodies.
    Yamaguchi R; Iwai H; Ueda K
    Microbiol Immunol; 1989; 33(2):133-9. PubMed ID: 2541319
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Altered cell-fusion capacity in lines of KB cells resistant to Sendai virus-induced cytolysis.
    Toyama S; Toyama S; Uetake H
    Virology; 1977 Feb; 76(2):503-15. PubMed ID: 190765
    [No Abstract]   [Full Text] [Related]  

  • 89. Activation of the Sendai virus fusion protein (f) involves a conformational change with exposure of a new hydrophobic region.
    Hsu M; Scheid A; Choppin PW
    J Biol Chem; 1981 Apr; 256(7):3557-63. PubMed ID: 6259173
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein.
    Alymova IV; Portner A; Mishin VP; McCullers JA; Freiden P; Taylor GL
    Glycobiology; 2012 Feb; 22(2):174-80. PubMed ID: 21846691
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in mice.
    Luque LE; Bridges OA; Mason JN; Boyd KL; Portner A; Russell CJ
    J Virol; 2010 Jan; 84(2):810-21. PubMed ID: 19906935
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Spring-loaded heptad repeat residues regulate the expression and activation of paramyxovirus fusion protein.
    Luque LE; Russell CJ
    J Virol; 2007 Apr; 81(7):3130-41. PubMed ID: 17251293
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Sequence motifs and prokaryotic expression of the reptilian paramyxovirus fusion protein.
    Franke J; Batts WN; Ahne W; Kurath G; Winton JR
    Arch Virol; 2006 Mar; 151(3):449-64. PubMed ID: 16328138
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Antigenic structure of human respiratory syncytial virus fusion glycoprotein.
    López JA; Bustos R; Orvell C; Berois M; Arbiza J; García-Barreno B; Melero JA
    J Virol; 1998 Aug; 72(8):6922-8. PubMed ID: 9658147
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The M2 ectodomain is important for its incorporation into influenza A virions.
    Park EK; Castrucci MR; Portner A; Kawaoka Y
    J Virol; 1998 Mar; 72(3):2449-55. PubMed ID: 9499106
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection.
    Atabani SF; Obeid OE; Chargelegue D; Aaby P; Whittle H; Steward MW
    J Virol; 1997 Oct; 71(10):7240-5. PubMed ID: 9311797
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Identification of an amino acid that defines the fusogenicity of mumps virus.
    Tanabayashi K; Takeuchi K; Okazaki K; Hishiyama M; Yamada A
    J Virol; 1993 May; 67(5):2928-31. PubMed ID: 8474181
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Assignment of disulfide bridges in the fusion glycoprotein of Sendai virus.
    Iwata S; Schmidt AC; Titani K; Suzuki M; Kido H; Gotoh B; Hamaguchi M; Nagai Y
    J Virol; 1994 May; 68(5):3200-6. PubMed ID: 8151783
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Measles virus fusion: role of the cysteine-rich region of the fusion glycoprotein.
    Wild TF; Fayolle J; Beauverger P; Buckland R
    J Virol; 1994 Nov; 68(11):7546-8. PubMed ID: 7933140
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Molecular characterization of a structural epitope that is largely conserved among severe isolates of a plant virus.
    Pappu HR; Pappu SS; Manjunath KL; Lee RF; Niblett CL
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3641-4. PubMed ID: 7682715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.